Skip to content
Review Open access

Covalent organic frameworks: Smart nanoarchitectures for targeted cancer therapy and imaging

Aug 2026 · MRS bulletin · Vol 51, pp. 1201 - 1214 · 0 citations · 69 references

TL;DR

Recent breakthroughs in design and biomedical applications of COFs as smart drug carriers are overviewed with a particular focus on their potential in cancer imaging and therapy and their potential to synergistically enhance the immune response and be coupled with emerging immunotherapy.

Abstract

Cancer remains one of the leading causes of death worldwide and requires new and targeted approaches for early detection and treatment. Covalent organic frameworks (COFs) are emerging as promising nanostructured materials for cancer applications. With remarkable properties such as tunable pore size and high specific surface area, chemical stability, and good biocompatibility, COFs can effectively encapsulate and release drugs, reducing drug toxicity while targeting tumor tissues. In this article, we overview recent breakthroughs in design and biomedical applications of COFs as smart drug carriers with a particular focus on their potential in cancer imaging and therapy. This manuscript also explores the potential of COFs to synergistically enhance the immune response and be coupled with emerging immunotherapy. Further research and translation of these materials offer exciting prospects for next-generation cancer theranostics.

Read PDF

Similar papers

Review Open access Sep 2026

Cancer Drug Delivery with Nanoparticles and Biomolecules: Stimuli-Responsive, Theranostic, and AI-Guided Approaches

This review examines the main classes of nanoplatforms currently explored for cancer therapy, including inorganic, polymeric, lipid-based, and hybrid organic–inorganic systems, and considers emerging directions in AI-guided nanoparticle engineerization design and natural-compound-based nanomedicines, both of which are...

C. Boncristiani, F. Baldassarre, Khadija Eddahaoui et al. · 0 citations
Review Open access Aug 2026

Advances in metal-organic frameworks (MOFs) for nanotheranostics: from targeted drug delivery to multimodal imaging

The integration of diagnostic and therapy into a single nanoplatform has been proved to be a revolutionary approach for precision medicine, which allows the simultaneous disease detection, treatment, and therapeutic monitoring. Although great progress has been achieved in nanotheranostics, many traditional nanomaterial...

Shiva Velayati, Masoumeh Zahmatkeshan, Naghmeh Farzaneh et al. · 1 citation
Review Aug 2026

Biomimetic cell-membrane-coated metallic nanoparticles in cancer therapy: Design, functional mechanisms, and translational challenges.

Cancer remains a major health concern worldwide, with the need to identify better and more specific treatment measures. The concept of using metallic nanoparticles in drug delivery has attracted significant attention due to their distinct physicochemical characteristics, including surface area, size, and multifunctiona...

Hiti Narula, R. Kamal, Thakur Gurjeet Singh et al. · 0 citations
Review Open access Sep 2026

Bio-Polymers Based Functionalized Hydrogel Carriers for Targeted Oncology Therapies: Current Progress and Future Perspectives

Abstract Challenges in cancer therapy remain in terms of lack of tumor selectivity, unwanted side effects, and inefficacy of current treatment strategies. Over the past few years, functionalized bio-polymer gels have become attractive alternatives for cancer therapy, as they are biocompatible and can be tailored to pro...

Sheng-Chun Qiu, Xiao-Yan Wen · 0 citations
Review Open access 2026

Stimuli-responsive nanocarriers for precision cancer therapy: a short communication

The paper reviews current developments concerning stimulus-responsive nanoparticles; it also describes how these agents work as a means to treat cancers precisely.

C. J. Jiflin, Mohana Sundaram Somasundharam Pushpanathan, Jeevitha Dhayalan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.